Management of the major complications of cirrhosis: Beyond guidelines

被引:30
作者
Carlos Garcia-Pagan, Juan [1 ,2 ]
Francoz, Claire [3 ,4 ]
Montagnese, Sara [5 ]
Senzolo, Marco [6 ]
Mookerjee, Rajeshwar P. [7 ,8 ]
机构
[1] Univ Barcelona, Barcelona Hepat Hemodynam Lab, Inst Invest Biomed August Pi & Sunyer IDIBAPs, Liver Unit,Hosp Clin,Ctr Invest Biomed Red Enferm, Barcelona, Spain
[2] Hop Beaujon, Hlth Care Provider European Reference Network Rar, Clichy, France
[3] Hop Beaujon, Hepatol & Liver Intens Care Unit, Clichy, France
[4] INSERM, Paris, France
[5] Univ Padua, Dept Med, Padua, Italy
[6] Univ Hosp Padua, Gastroenterol Multivisceral Transplant Unit, Dept Surg Oncol & Gastroenterol, Padua, Italy
[7] UCL, Inst Liver & Digest Hlth, London NW3 2PF, England
[8] Aarhus Univ, Dept Hepatol & Gastroenterol, Aarhus, Denmark
关键词
Cirrhosis; Decompensation; Management; Guidelines; Controversies; INTRAHEPATIC PORTOSYSTEMIC SHUNT; NONSELECTIVE BETA-BLOCKERS; ACUTE HEMODYNAMIC-RESPONSE; SPONTANEOUS BACTERIAL PERITONITIS; REFRACTORY ASCITES; HEPATIC-ENCEPHALOPATHY; RENAL-FUNCTION; DECOMPENSATED CIRRHOSIS; PROGNOSTIC-SIGNIFICANCE; LIVER-TRANSPLANTATION;
D O I
10.1016/j.jhep.2021.01.027
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Along with a growing understanding of the pathophysiology of cirrhosis and its complications, new therapies and management strategies have emerged in recent years. Many of these advances have helped inform the current EASL clinical practice guidelines(1) on the management of some of the key complications of cirrhosis, such as ascites, variceal bleeding and infection. However, there are still some aspects of management where the evidence base is less clear, and/or where opinions amongst practitioners remain divided. Some of these more controversial areas are explored in this section, wherein we present evidence culminating in a suggested management approach based on expert opinion and extending beyond the current guidelines. (C) 2021 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码:S135 / S146
页数:12
相关论文
共 97 条
  • [31] Survival after elective transjugular intrahepatic portosystemic shunt creation: Prediction with model for end-stage liver disease score
    Ferral, H
    Gamboa, P
    Postoak, DW
    Albernaz, VS
    Young, CR
    Speeg, KV
    McMahan, CA
    [J]. RADIOLOGY, 2004, 231 (01) : 231 - 236
  • [32] Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
    Ferrarese, Alberto
    Tikhonoff, Valerie
    Casiglia, Edoardo
    Angeli, Paolo
    Fasolato, Silvano
    Faggian, Diego
    Zanetto, Alberto
    Germani, Giacomo
    Russo, Francesco Paolo
    Burra, Patrizia
    Senzolo, Marco
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [33] Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension
    Ferrarese, Alberto
    Zanetto, Alberto
    Germani, Giacomo
    Burra, Patrizia
    Senzolo, Marco
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2016, 8 (24) : 1012 - 1018
  • [34] Glomerular Filtration Rate Equations for Liver-Kidney Transplantation in Patients With Cirrhosis: Validation of Current Recommendations
    Francoz, Claire
    Nadim, Mitra K.
    Baron, Aurore
    Prie, Dominique
    Antoine, Corinne
    Belghiti, Jacques
    Valla, Dominique
    Moreau, Richard
    Durand, Francois
    [J]. HEPATOLOGY, 2014, 59 (04) : 1514 - 1521
  • [35] The evaluation of renal function and disease in patients with cirrhosis
    Francoz, Claire
    Glotz, Denis
    Moreau, Richard
    Durand, Francois
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (04) : 605 - 613
  • [36] Gaba R C, 2015, Clin Radiol, V70, pe51, DOI 10.1016/j.crad.2015.02.002
  • [37] Beta-Blockers Have No Effect on Outcomes in Patients with Cirrhosis and Severe Infections
    Galbois, Arnaud
    Das, Vincent
    Thabut, Dominique
    Maury, Eric
    Ait-Oufella, Hafid
    Housset, Chantal
    Guidet, Bertrand
    [J]. HEPATOLOGY, 2011, 53 (04) : 1412 - 1413
  • [38] The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions
    Ganapathy, Dinesh
    Acharya, Chathur
    Lachar, Jatinder
    Patidar, Kavish
    Sterling, Richard K.
    White, Melanie B.
    Ignudo, Catherine
    Bommidi, Swamy
    DeSoto, John
    Thacker, Leroy R.
    Matherly, Scott
    Shaw, Jawaid
    Siddiqui, Mohammad S.
    Puri, Puneet
    Sanyal, Arun J.
    Luketic, Velimir
    Lee, Hannah
    Stravitz, Richard T.
    Bajaj, Jasmohan S.
    [J]. LIVER INTERNATIONAL, 2017, 37 (12) : 1843 - 1851
  • [39] Gangopadhyay Kalyan Kumar, 2017, Indian J Endocrinol Metab, V21, P341, DOI 10.4103/ijem.IJEM_512_16
  • [40] Garcia MS, 2019, IEEE ENG MED BIO, P1371, DOI [10.1109/EMBC.2019.8857239, 10.1109/embc.2019.8857239]